Production and Quality Control of [<sup>67</sup>Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy
| Author | Behrooz Alirezapour | en |
| Author | Amir R. Jalilian | en |
| Author | Fatemeh Bolourinovin | en |
| Author | Sedigheh Moradkhani | en |
| Issued Date | 2013-04-30 | en |
| Abstract | Breast cancer radioimmunoscintigraphy targeting HER2/neu expression is a growing field of work in nuclear medicine research. In this study, trastuzumab was successively labeled with [67Ga] GaCl3 after conjugation with DOTA-NHS-ester. | en |
| DOI | https://doi.org/10.22037/ijpr.2013.1314 | en |
| Keyword | Gallium-67 | en |
| Keyword | Trastuzumab | en |
| Keyword | Radiolabeling | en |
| Keyword | Conjugation | en |
| Keyword | Biodistribution | en |
| Publisher | Brieflands | en |
| Title | Production and Quality Control of [<sup>67</sup>Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-12-355.pdf
- Size:
- 800.02 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF